This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...

FDA officials say it will need three months to thoroughly analyze data on possible cardiac risk associated with Nexium and Prilosec, both proton pump inhibitors used to treat heartburn and reflux ...

Dr Punam Krishan has told anyone taking PPIs like omeprazole for heartburn, acid reflux, or indigestion to do one thing ...

WASHINGTON — U.S. regulators said Monday that they had cleared AstraZeneca’s bestselling heartburn drugs Prilosec and Nexium of links to heart problems, but disclosed a review of a potential risk of ...

Health Canada says it's reviewing new safety data on AstraZeneca's heartburn drugs Nexium and Prilosec. The preliminary data shows patients may have had more heart attacks and other cardiac problems ...

A popular category of heartburn medications -- including Nexium, Prevacid, Prilosec and Protonix -- may increase your risk of stroke, a new study suggests. Known as proton pump inhibitors (PPIs), ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

SATURDAY, Aug. 19, 2017 -- Widely used heartburn drugs called proton pump inhibitors do not appear to increase Alzheimer's disease risk, according to a new study. Prilosec, Nexium and Prevacid are ...

(RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. AstraZeneca (LSE: AZN) settled its patent litigation with Teva Pharmaceutical ...